Modest Profit From Its Covid-19 Vaccine Made By AstraZeneca
As the globe learns to live with the coronavirus, AstraZeneca said it will start to generate a small profit on its coronavirus vaccine, even as the pharmaceutical firm is in talks with several governments about further orders of its Covid-19 vaccine for delivery next year. During the pandemic, a pledge was made by AstraZeneca of…









